- Report
- May 2024
- 182 Pages
Global
From €3969EUR$4,500USD£3,436GBP
- Report
- May 2024
- 182 Pages
Global
From €3969EUR$4,500USD£3,436GBP
- Report
- October 2023
- 73 Pages
Canada
From €3087EUR$3,500USD£2,672GBP
- Report
- July 2024
- 258 Pages
Global
From €4366EUR$4,950USD£3,779GBP
- Report
- December 2024
- 87 Pages
Spain
From €3087EUR$3,500USD£2,672GBP
- Report
- July 2024
- 190 Pages
Global
From €3969EUR$4,500USD£3,436GBP
- Report
- July 2024
- 185 Pages
Global
From €3969EUR$4,500USD£3,436GBP
- Report
- July 2024
- 80 Pages
Japan
From €3087EUR$3,500USD£2,672GBP
- Report
- July 2024
- 189 Pages
Global
From €3969EUR$4,500USD£3,436GBP
- Report
- May 2024
- 182 Pages
Global
From €3969EUR$4,500USD£3,436GBP
- Report
- May 2024
- 184 Pages
Global
From €3969EUR$4,500USD£3,436GBP
- Report
- May 2024
- 185 Pages
Global
From €3969EUR$4,500USD£3,436GBP
- Report
- April 2024
- 183 Pages
Global
From €3969EUR$4,500USD£3,436GBP
- Report
- November 2023
- 78 Pages
France
From €3087EUR$3,500USD£2,672GBP
- Report
- November 2023
- 78 Pages
Germany
From €3087EUR$3,500USD£2,672GBP
- Report
- November 2023
- 83 Pages
Germany
From €3087EUR$3,500USD£2,672GBP
- Report
- May 2024
- 298 Pages
Global
From €7011EUR$7,950USD£6,070GBP
- Report
- May 2023
- 200 Pages
Global
From €6614EUR$7,500USD£5,726GBP
- Report
- May 2023
- 220 Pages
Global
From €2205EUR$2,500USD£1,909GBP
- Report
- May 2023
- 450 Pages
Global
From €4410EUR$5,000USD£3,817GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more